UNIVERSITY OF MIAMI HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $14.3M
- Transactions
- 1,952
- Companies
- 40
- Average per transaction
- $7,311
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $1,663,753 |
| Pfizer | $1,645,663 |
| Incyte Corporation | $1,493,925 |
| Servier Pharmaceuticals LLC | $1,390,620 |
| 4dmedical USA Inc | $1,010,000 |
| Intuitive Surgical | $936,138 |
| UCB SA | $636,022 |
| Servier Bioinnovation | $566,491 |
| Plexxikon Inc. | $483,977 |
| Angiodynamics, Inc. | $465,250 |
| Novartis | $418,760 |
| Viewray Technologies Inc | $228,497 |
| Alcon | $228,250 |
| Endo USA, Inc. | $181,200 |
| Eisai Inc. | $178,986 |
| Rigel Pharmaceuticals, Inc. | $162,521 |
| Spineology Inc. | $135,746 |
| Carl Zeiss Meditec, Inc. | $132,362 |
| Boston Scientific | $132,115 |
| Genentech, Inc. | $125,000 |
| KCI USA, Inc. | $114,000 |
| Medtronic | $111,707 |
| Genentech USA, Inc. | $104,750 |
| NX Development Corp. | $101,476 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $80,292 |
| Tesaro, Inc. | $80,287 |
| Globus Medical | $78,150 |
| Heidelberg Engineering, Inc. | $73,750 |
| Immedica Pharma US, Inc. | $64,830 |
| Molnlycke Health Care US, LLC | $62,445 |
| Amgen | $59,198 |
| Bausch & Lomb Americas Inc. | $58,750 |
| E.r. Squibb & Sons, L.L.C. | $58,049 |
| GSK | $46,038 |
| Osteomed LLC | $44,670 |
| Glaukos Corporation | $38,876 |
| Iovance Biotherapeutics, Inc. | $38,846 |
| Carl Zeiss Meditec USA, Inc. | $38,004 |
| Cathworks, Inc. | $36,243 |
| Agios Pharmaceuticals, Inc. | $34,762 |